Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Swift Biosciences Introduces Fast, Easy Workflow

Published: Thursday, June 27, 2013
Last Updated: Thursday, June 27, 2013
Bookmark and Share
Swift Biosciences, Inc. announced an Early Access Program for the Accel-NGS™ DNA Library Kit for NGS systems.

This program follows the successful launch earlier this year of a similar product for use on Ion Torrent platforms.  Swift’s new kit is designed to bring the same benefits - low input requirement, PCR-free capability and fast, easy workflow - to the Illumina platform.  MiSeq and HiSeq users who register for this Early Access Program will be able to experience the benefits of the Accel-NGS technology before the product is widely released and will receive introductory pricing.

With the Accel-NGS DNA Library Kit for Illumina, scientists can now produce high complexity, PCR-free libraries with as little as 250 ng of input DNA.  Libraries at significantly lower input levels can be produced with a few cycles of PCR.   Unlike other products, the Accel-NGS DNA Library Kit does not require intact double-stranded DNA, making it fully compatible with FFPE and damaged samples. Swift’s unique, sequential adaptation process also reduces adapter dimer formation to further maximize sequencing output.

The Accel-NGS DNA Library Kit for Illumina protocol is fast, requiring approximately 90 minutes start-to-finish, and consists of a handful of easy steps, including bead-based separations that eliminate the need for time-consuming, electrophoretic gel-based size selection.  The streamlined Accel-NGS workflow is also suitable for automation.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Swift Biosciences Announces $7 Million Series B Financing
Funds will support development of next gen sequencing and molecular diagnostic products.
Friday, October 18, 2013
Michigan Accelerator Fund I Invests $750,000 in Swift Biosciences
Innovative company develops enabling technologies for genomics and personalized medicine.
Friday, January 18, 2013
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!